is part of the Informa Markets Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Approximately 15% of laboratory services are carried out in independent laboratories in the KSA. Hospitals deal with almost 70% of test volumes and lower specialization levels, forcing them to outsource tests. As a result, the outsourcing of tests has been a primary driver of growth for independent labs and will continue to provide a stimulus. KSA has faced the challenge of two viral outbreaks — MERS-CoV since 2012 and COVID-19 (SARS-CoV-2) in 2020 — which require self-contained diagnostic facilities for efficient diagnosis and control. Clinical services outsourcing offers immediate support to struggling hospitals in terms of resources and costs. It allows for more successful navigation through cumbersome reimbursement processes and bad debt challenges. The hospital business also eliminates the front-end and back-end costs associated with specimen acquisition and report delivery. The heightened burden of chronic diseases, requiring frequent testing, demands continuous participation of clinical labs throughout the entire course of treatment.